Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies
2011

Time Courses of Improvement in Children with ADHD Treated with Atomoxetine

Sample size: 338 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dickson Ruth A, Maki Ellen, Gibbins Christopher, Gutkin Stephen W, Turgay Atilla, Weiss Margaret D

Primary Institution: Eli Lilly Canada, Toronto, Canada and University of Calgary, Alberta, Canada

Hypothesis

What are the time courses of treatment responses or remission in children with ADHD treated with atomoxetine?

Conclusion

Children's ADHD symptoms improve gradually with atomoxetine treatment, with significant improvement seen by 1 month and remission typically not achieved until about 3 months.

Supporting Evidence

  • The median time to improvement was 3.7 weeks.
  • Probabilities of remission were 30% at 4 weeks and 85% at 52 weeks using the ADHDRS-IV scale.
  • Remission using the CGI-ADHD-S scale was achieved at a median of 14.3 weeks.

Takeaway

Kids taking atomoxetine for ADHD start feeling better in about a month, but it takes a bit longer—around 3 months—to feel really good.

Methodology

Pooled data from three Canadian open-label studies involving children aged 6-11 years treated with atomoxetine for up to 1 year.

Potential Biases

Potential positive clinician bias due to the open-label study design.

Limitations

The study's findings may not generalize beyond Canadian children aged 6-11, and the open-label design may have introduced bias.

Participant Demographics

The sample comprised 249 boys (73.7%) and 89 girls (26.3%) with a mean age of 8.7 years.

Statistical Information

P-Value

0.33

Statistical Significance

p = .33

Digital Object Identifier (DOI)

10.1186/1753-2000-5-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication